Eptinezumab in patients with prior failure to other anti-CGRP monoclonal antibodies compared to naive patients: A real-world study in two Portuguese hospitals

Authors
Category Primary study
Conference19th European Headache Congress, EHC
Year 2026
This article has no abstract
Epistemonikos ID: 87179339c140b26a1d22dc776e5f180ea0ca1560
First added on: Aug 15, 2026